KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Corpay (CPAY) Asset Writedowns and Impairment (2016 - 2025)

Historic Asset Writedowns and Impairment for Corpay (CPAY) over the last 16 years, with Q3 2025 value amounting to $27.7 million.

  • Corpay's Asset Writedowns and Impairment fell 141.4% to $27.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $111.4 million, marking a year-over-year increase of 793.95%. This contributed to the annual value of $103.1 million for FY2024, which is 1759.38% down from last year.
  • According to the latest figures from Q3 2025, Corpay's Asset Writedowns and Impairment is $27.7 million, which was down 141.4% from $31.5 million recorded in Q2 2025.
  • In the past 5 years, Corpay's Asset Writedowns and Impairment ranged from a high of $41.1 million in Q4 2022 and a low of $2.5 million during Q1 2021
  • Its 5-year average for Asset Writedowns and Impairment is $25.6 million, with a median of $27.7 million in 2025.
  • In the last 5 years, Corpay's Asset Writedowns and Impairment plummeted by 9789.63% in 2021 and then skyrocketed by 92858.3% in 2022.
  • Corpay's Asset Writedowns and Impairment (Quarter) stood at $18.5 million in 2021, then skyrocketed by 122.27% to $41.1 million in 2022, then plummeted by 47.33% to $21.7 million in 2023, then dropped by 0.39% to $21.6 million in 2024, then grew by 28.31% to $27.7 million in 2025.
  • Its Asset Writedowns and Impairment stands at $27.7 million for Q3 2025, versus $31.5 million for Q2 2025 and $30.7 million for Q1 2025.